380 related articles for article (PubMed ID: 28002790)
1. Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.
Selt F; Hohloch J; Hielscher T; Sahm F; Capper D; Korshunov A; Usta D; Brabetz S; Ridinger J; Ecker J; Oehme I; Gronych J; Marquardt V; Pauck D; Bächli H; Stiles CD; von Deimling A; Remke M; Schuhmann MU; Pfister SM; Brummer T; Jones DT; Witt O; Milde T
Oncotarget; 2017 Feb; 8(7):11460-11479. PubMed ID: 28002790
[TBL] [Abstract][Full Text] [Related]
2. The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma.
Buhl JL; Selt F; Hielscher T; Guiho R; Ecker J; Sahm F; Ridinger J; Riehl D; Usta D; Ismer B; Sommerkamp AC; Martinez-Barbera JP; Wefers AK; Remke M; Picard D; Pusch S; Gronych J; Oehme I; van Tilburg CM; Kool M; Kuhn D; Capper D; von Deimling A; Schuhmann MU; Herold-Mende C; Korshunov A; Brummer T; Pfister SM; Jones DTW; Witt O; Milde T
Clin Cancer Res; 2019 Mar; 25(6):1851-1866. PubMed ID: 30530705
[TBL] [Abstract][Full Text] [Related]
3. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas.
Jacob K; Quang-Khuong DA; Jones DT; Witt H; Lambert S; Albrecht S; Witt O; Vezina C; Shirinian M; Faury D; Garami M; Hauser P; Klekner A; Bognar L; Farmer JP; Montes JL; Atkinson J; Hawkins C; Korshunov A; Collins VP; Pfister SM; Tabori U; Jabado N
Clin Cancer Res; 2011 Jul; 17(14):4650-60. PubMed ID: 21610151
[TBL] [Abstract][Full Text] [Related]
4. Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow.
Selt F; El Damaty A; Schuhmann MU; Sigaud R; Ecker J; Sievers P; Kocher D; Herold-Mende C; Oehme I; von Deimling A; Pfister SM; Sahm F; Jones DTW; Witt O; Milde T
J Neurooncol; 2023 Dec; 165(3):467-478. PubMed ID: 37999877
[TBL] [Abstract][Full Text] [Related]
5. A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in
Usta D; Sigaud R; Buhl JL; Selt F; Marquardt V; Pauck D; Jansen J; Pusch S; Ecker J; Hielscher T; Vollmer J; Sommerkamp AC; Rubner T; Hargrave D; van Tilburg CM; Pfister SM; Jones DTW; Remke M; Brummer T; Witt O; Milde T
Mol Cancer Ther; 2020 Aug; 19(8):1736-1750. PubMed ID: 32451331
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma.
Cin H; Meyer C; Herr R; Janzarik WG; Lambert S; Jones DT; Jacob K; Benner A; Witt H; Remke M; Bender S; Falkenstein F; Van Anh TN; Olbrich H; von Deimling A; Pekrun A; Kulozik AE; Gnekow A; Scheurlen W; Witt O; Omran H; Jabado N; Collins VP; Brummer T; Marschalek R; Lichter P; Korshunov A; Pfister SM
Acta Neuropathol; 2011 Jun; 121(6):763-74. PubMed ID: 21424530
[TBL] [Abstract][Full Text] [Related]
7. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model.
Raabe EH; Lim KS; Kim JM; Meeker A; Mao XG; Nikkhah G; Maciaczyk J; Kahlert U; Jain D; Bar E; Cohen KJ; Eberhart CG
Clin Cancer Res; 2011 Jun; 17(11):3590-9. PubMed ID: 21636552
[TBL] [Abstract][Full Text] [Related]
8. Detection of the KIAA1549-BRAF fusion gene in cells forming microvascular proliferations in pilocytic astrocytoma.
Yamashita S; Takeshima H; Matsumoto F; Yamasaki K; Fukushima T; Sakoda H; Nakazato M; Saito K; Mizuguchi A; Watanabe T; Ohta H; Yokogami K
PLoS One; 2019; 14(7):e0220146. PubMed ID: 31329636
[TBL] [Abstract][Full Text] [Related]
9. The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features.
Cykowski MD; Allen RA; Kanaly AC; Fung KM; Marshall R; Perry A; Stolzenberg ED; Dunn ST
J Neurooncol; 2013 Dec; 115(3):477-86. PubMed ID: 24057326
[TBL] [Abstract][Full Text] [Related]
10. A novel GIT2-BRAF fusion in pilocytic astrocytoma.
Helgager J; Lidov HG; Mahadevan NR; Kieran MW; Ligon KL; Alexandrescu S
Diagn Pathol; 2017 Nov; 12(1):82. PubMed ID: 29141672
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of disseminated pilocytic astrocytomas.
Gessi M; Engels AC; Lambert S; Rothämel T; von Hornstein S; Collins VP; Denkhaus D; Gnekow A; Pietsch T
Neuropathol Appl Neurobiol; 2016 Apr; 42(3):273-8. PubMed ID: 26084390
[TBL] [Abstract][Full Text] [Related]
12. A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.
Tomić TT; Olausson J; Wilzén A; Sabel M; Truvé K; Sjögren H; Dósa S; Tisell M; Lannering B; Enlund F; Martinsson T; Åman P; Abel F
PLoS One; 2017; 12(4):e0175638. PubMed ID: 28448514
[TBL] [Abstract][Full Text] [Related]
13. KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis.
Antonelli M; Badiali M; Moi L; Buttarelli FR; Baldi C; Massimino M; Sanson M; Giangaspero F
Pediatr Blood Cancer; 2015 Apr; 62(4):724-7. PubMed ID: 25382612
[TBL] [Abstract][Full Text] [Related]
14. Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas.
Tian Y; Rich BE; Vena N; Craig JM; Macconaill LE; Rajaram V; Goldman S; Taha H; Mahmoud M; Ozek M; Sav A; Longtine JA; Lindeman NI; Garraway LA; Ligon AH; Stiles CD; Santagata S; Chan JA; Kieran MW; Ligon KL
J Mol Diagn; 2011 Nov; 13(6):669-77. PubMed ID: 21884820
[TBL] [Abstract][Full Text] [Related]
15. Pilocytic astrocytomas: BRAFV600E and BRAF fusion expression patterns in pediatric and adult age groups.
Kurani H; Gurav M; Shetty O; Chinnaswamy G; Moiyadi A; Gupta T; Jalali R; Epari S
Childs Nerv Syst; 2019 Sep; 35(9):1525-1536. PubMed ID: 31321520
[TBL] [Abstract][Full Text] [Related]
16. Whole Chromosome 7 Gain Predicts Higher Risk of Recurrence in Pediatric Pilocytic Astrocytomas Independently From KIAA1549-BRAF Fusion Status.
Roth JJ; Fierst TM; Waanders AJ; Yimei L; Biegel JA; Santi M
J Neuropathol Exp Neurol; 2016 Apr; 75(4):306-15. PubMed ID: 26945035
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas.
Kumar A; Pathak P; Purkait S; Faruq M; Jha P; Mallick S; Suri V; Sharma MC; Suri A; Sarkar C
Cancer Genet; 2015 Mar; 208(3):91-5. PubMed ID: 25794445
[TBL] [Abstract][Full Text] [Related]
18. Chromosome band 7q34 deletions resulting in KIAA1549-BRAF and FAM131B-BRAF fusions in pediatric low-grade Gliomas.
Roth JJ; Santi M; Pollock AN; Harding BN; Rorke-Adams LB; Tooke LS; Biegel JA
Brain Pathol; 2015 Mar; 25(2):182-92. PubMed ID: 25040262
[TBL] [Abstract][Full Text] [Related]
19. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
[TBL] [Abstract][Full Text] [Related]
20. Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors.
Lee RP; Foster KA; Lillard JC; Klimo P; Ellison DW; Orr B; Boop FA
J Neurosurg Pediatr; 2017 Sep; 20(3):247-255. PubMed ID: 28686121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
